Intralink Spine???s R??juve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study Post author:Sam Post published:January 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>ISPE</b> Releases The New Cultural Excellence Report May 7, 2017 GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock June 27, 2017 Bay Area's Adamas Pharma Pays Big Bucks to Double HQ January 21, 2018